Tofacitinib Impurities and its Related Products
Home > Impurities > Tofacitinib > Product Listing of Tofacitinib Impurities
Tofacitinib Impurities refer to any unwanted or unintended substances that may be present in the pharmaceutical product Tofacitinib, which is used to treat rheumatoid arthritis and other autoimmune diseases. These impurities could be residual solvents, degradation products, or other contaminants that may arise during the manufacturing, storage or transportation of the drug. It is important to monitor and control the levels of these impurities to ensure the safety and efficacy of the drug.
TOFACITINIB IMPURITIES, IMPURITIES
(3R,4S)-Tofacitinib citirate
| CAT No. | : CS-O-39729 |
| Mol F. | : C22H28N6O8 |
| Mol W. | : 504.49 g/mol |
| Cas No. | : 2174011-53-9 |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
(3R,4S)-Tofacitinib
| CAT No. | : CS-T-62103 |
| Mol F. | : C₁₆H₂₀N₆O |
| Mol W. | : 312.37 g/mol |
| Cas No. | : 1092578-46-5 |
| Stock | : IN-Stock |
TOFACITINIB IMPURITIES, IMPURITIES
(3S,4R)-Tofacitinib
| CAT No. | : CS-T-62105 |
| Mol F. | : C₁₆H₂₀N₆O |
| Mol W. | : 312.37 g/mol |
| Cas No. | : 1092578-48-7 |
| Stock | : IN-Stock |
TOFACITINIB IMPURITIES, IMPURITIES
(3S,4S)-Tofacitinib
| CAT No. | : CS-T-62104 |
| Mol F. | : Not Available |
| Mol W. | : Not Available |
| Cas No. | : 1092578-47-6 |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
1,2,3,6,-tetrahydro-1- nitroso4-picoline
| CAT No. | : CS-O-45591 |
| Mol F. | : C6H10N2O |
| Mol W. | : 126.16 g/mol |
| Cas No. | : 89600-66-8 |
| Stock | : Enquire |
![3-((3R,4R)-4-methyl-3-(methyl((5R,6S)-2,5,6-trihydroxy-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)a](https://clearsynth.com/structure/3---3R-4R--4-methyl-3--methyl--5R-6S--2-5-6-trihydroxy-6-7-dihydro-5H-pyrrolo-2-3-d-pyrimidin-4-yl-a.png "Tofacitinib Impurities")
TOFACITINIB IMPURITIES, IMPURITIES
3-((3R,4R)-4-methyl-3-(methyl((5R,6S)-2,5,6-trihydroxy-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)a
| CAT No. | : CS-O-35885 |
| Mol F. | : C16H22N6O4 |
| Mol W. | : 362.68 g/mol |
| Cas No. | : 2102039-98-3 |
| Stock | : Enquire |
![3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropaneni](https://clearsynth.com/structure/3---3R-4R--4-methyl-3--methyl--7H-pyrrolo-2-3-d-pyrimidin-4-yl--amino-piperidin-1-yl--3-oxopropaneni.png "Tofacitinib Impurities")
TOFACITINIB IMPURITIES, IMPURITIES
3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropaneni
| CAT No. | : CS-O-36711 |
| Mol F. | : C16H20N6O3 |
| Mol W. | : 344.37 g/mol |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
N-(1-benzyl-4-methylpiperidin-3-yl)-N-methylnitrous amide
| CAT No. | : CS-O-45589 |
| Mol F. | : C14H21N3O |
| Mol W. | : 247.34 g/mol |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
N,4-dimethyl-1-nitrosopiperidin-3-amine
| CAT No. | : CS-O-45597 |
| Mol F. | : C7H15N3O |
| Mol W. | : 157.21 g/mol |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
N-methyl-N-(4-methyl-1-nitrosopiperidin-3-yl)nitrous amide
| CAT No. | : CS-O-45598 |
| Mol F. | : C7H14N4O2 |
| Mol W. | : 186.21 g/mol |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
N-methyl-N-(4-methylpiperidin-3-yl)nitrous amide
| CAT No. | : CS-O-45599 |
| Mol F. | : C7H15N3O |
| Mol W. | : 157.21 g/mol |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
N-methyl-N-(4-methylpyridin-3-yl)nitrous amide
| CAT No. | : CS-O-46286 |
| Mol F. | : C7H9N3O |
| Mol W. | : 151.17 g/mol |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
N-Nitroso Tofacitinib Amine Impurity
| CAT No. | : CS-O-40197 |
| Mol F. | : C₁₃H₁₈N₆O |
| Mol W. | : 274.32 g/mol |
| Cas No. | : Not Available |
| Stock | : IN-Stock |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib formyl impurity
| CAT No. | : CS-EO-01760 |
| Mol F. | : C₁₄H₁₉N₅O |
| Mol W. | : 273.33 g/mol |
| Cas No. | : 2227199-28-0 |
| Stock | : IN-Stock |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib butyl ester impurity
| CAT No. | : CS-O-43010 |
| Mol F. | : C23H31N7O3 |
| Mol W. | : 453.54 g/mol |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib Citrate Diasteromeric impurity
| CAT No. | : CS-O-46779 |
| Mol F. | : C22H28N6O8 |
| Mol W. | : 504.49 g/mol |
| Cas No. | : 2664002-63-3 |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib Diastereomer
| CAT No. | : CS-EO-00128 |
| Mol F. | : C₂₂H₂₈N₆O₈ |
| Mol W. | : 504.49 g/mol |
| Cas No. | : 344418-92-4 (Freebase) |
| Stock | : IN-Stock |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib Dihydro Citricacid salt impurity
| CAT No. | : CS-O-44098 |
| Mol F. | : C22H30N6O8 |
| Mol W. | : 506.51 g/mol |
| Cas No. | : 1809002-40-1 |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib Dihydro Impurity
| CAT No. | : CS-T-89311 |
| Mol F. | : C₁₆H₂₂N₆O |
| Mol W. | : 314.39 g/mol |
| Cas No. | : 1640972-35-5 |
| Stock | : IN-Stock |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib Hydroxy Impurity
| CAT No. | : CS-EO-02225 |
| Mol F. | : C16H20N6O2 |
| Mol W. | : 328.37 g/mol |
| Cas No. | : 1092578-46-5 |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib Impurity (N-Des-(2-Cyanide-acetyl)-(3S,4R))
| CAT No. | : CS-EO-01834 |
| Mol F. | : C13H19N5 |
| Mol W. | : 245.3 g/mol |
| Cas No. | : 2378663-15-9 |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib Impurity 29
| CAT No. | : CS-EO-03056 |
| Mol F. | : C21H27N7O3 |
| Mol W. | : 425.5 g/mol |
| Cas No. | : 2459302-85-1 |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib Impurity 57
| CAT No. | : CS-EO-03055 |
| Mol F. | : C32H40N12O2 |
| Mol W. | : 624.8 g/mol |
| Cas No. | : 2315287-12-6 |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib Impurity 6
| CAT No. | : CS-EO-01450 |
| Mol F. | : C₁₉H₂₂N₈ |
| Mol W. | : 362.40 g/mol |
| Cas No. | : 2504210-38-0 |
| Stock | : IN-Stock |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib impurity C
| CAT No. | : CS-AQ-00034 |
| Mol F. | : Not Available |
| Mol W. | : Not Available |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib impurity F
| CAT No. | : CS-AQ-00036 |
| Mol F. | : Not Available |
| Mol W. | : Not Available |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib impurity G
| CAT No. | : CS-AQ-00037 |
| Mol F. | : C₁₄H₂₄Cl₂N₂ |
| Mol W. | : 291.26 g/mol |
| Cas No. | : 1354486-07-9 |
| Stock | : IN-Stock |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib impurity I
| CAT No. | : CS-AQ-00038 |
| Mol F. | : Not Available |
| Mol W. | : Not Available |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib impurity J
| CAT No. | : CS-AQ-00039 |
| Mol F. | : Not Available |
| Mol W. | : Not Available |
| Cas No. | : 1431697-80-1 |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib impurity K
| CAT No. | : CS-AQ-00040 |
| Mol F. | : C16H21N5O3 |
| Mol W. | : 331.4 g/mol |
| Cas No. | : 2328165-36-0 |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib impurity L
| CAT No. | : CS-AQ-00041 |
| Mol F. | : C₁₆H₂₂N₅O₂ |
| Mol W. | : 330.38 g/mol |
| Cas No. | : 1675248-19-7 |
| Stock | : IN-Stock |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib impurity N
| CAT No. | : CS-AQ-00042 |
| Mol F. | : Not Available |
| Mol W. | : Not Available |
| Cas No. | : 1260614-73-0 |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib impurity P
| CAT No. | : CS-AQ-00044 |
| Mol F. | : Not Available |
| Mol W. | : Not Available |
| Cas No. | : 1252883-90-1 |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib impurity T
| CAT No. | : CS-AQ-00046 |
| Mol F. | : Not Available |
| Mol W. | : Not Available |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
TOFACITINIB IMPURITY TOF-IV
| CAT No. | : CS-O-49452 |
| Mol F. | : C14H21N5 |
| Mol W. | : 259.35 g/mol |
| Cas No. | : 2227197-38-6 |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib impurity U
| CAT No. | : CS-AQ-00047 |
| Mol F. | : Not Available |
| Mol W. | : Not Available |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib impurity V
| CAT No. | : CS-AQ-00048 |
| Mol F. | : Not Available |
| Mol W. | : Not Available |
| Cas No. | : 1616761-00-2 |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib impurity W
| CAT No. | : CS-AQ-00049 |
| Mol F. | : Not Available |
| Mol W. | : Not Available |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib impurity X
| CAT No. | : CS-AQ-00050 |
| Mol F. | : Not Available |
| Mol W. | : Not Available |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib impurity Z
| CAT No. | : CS-AQ-00052 |
| Mol F. | : Not Available |
| Mol W. | : Not Available |
| Cas No. | : 477600-76-3 |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib- Keto Impurity
| CAT No. | : CS-DN-00028 |
| Mol F. | : Not Available |
| Mol W. | : Not Available |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib N- acid Impurity
| CAT No. | : CS-DN-00027 |
| Mol F. | : Not Available |
| Mol W. | : Not Available |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib N-hydroxy impurity
| CAT No. | : CS-EO-00807 |
| Mol F. | : C13H19N5O |
| Mol W. | : 261.33 g/mol |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib Nitroso Impurity
| CAT No. | : CS-EO-01989 |
| Mol F. | : C16H19N7O2 |
| Mol W. | : 341.4 g/mol |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib Nitroso Impurity 1
| CAT No. | : CS-O-45592 |
| Mol F. | : C13H20N6O |
| Mol W. | : 276.34 g/mol |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib Nitroso Impurity 2
| CAT No. | : CS-O-45593 |
| Mol F. | : C13H22N6O |
| Mol W. | : 278.35 g/mol |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib Nitroso Impurity 3
| CAT No. | : CS-O-45594 |
| Mol F. | : C13H19N7O2 |
| Mol W. | : 305.34 g/mol |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib Nitroso Impurity 4
| CAT No. | : CS-O-45595 |
| Mol F. | : C14H20N6O |
| Mol W. | : 288.35 g/mol |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib Nitroso Impurity 5
| CAT No. | : CS-O-45596 |
| Mol F. | : C14H22N6O |
| Mol W. | : 290.36 g/mol |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib N-Nitroso benzyl intermediate
| CAT No. | : CS-O-47117 |
| Mol F. | : C14H21N3O |
| Mol W. | : 247.34 g/mol |
| Cas No. | : Not Available |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib N-oxide
| CAT No. | : CS-T-89823 |
| Mol F. | : C16H20N6O2 |
| Mol W. | : 328.4 g/mol |
| Cas No. | : 2028267-73-2 |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib Related Compound 26 HCl
| CAT No. | : CS-P-02224 |
| Mol F. | : Not Available |
| Mol W. | : Not Available |
| Cas No. | : 1206824-85-2 |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib Related Compound 29
| CAT No. | : CS-EO-01845 |
| Mol F. | : C12H7ClN6 |
| Mol W. | : 270.7 g/mol |
| Cas No. | : 134965-85-8 |
| Stock | : Enquire |
TOFACITINIB IMPURITIES, IMPURITIES
Tofacitinib S,S Isomer
| CAT No. | : CS-O-33661 |
| Mol F. | : C16H20N6O : C6H8O7 |
| Mol W. | : 312.4 : 192.1 g/mol |
| Cas No. | : 2174011-55-1 |
| Stock | : Enquire |